Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Evaluating drug-drug interaction risk associated with peptide analogues using advanced in vitro systems
doi:10.1056/NEJMoa1103782
Patients should maintain realistic expectations during this initial phase
.png)
Article PubMed Google Scholar Wilding, J
Safety monitoring should account for several important risks: Diabetic retinopathy : Patients with existing retinopathy should be monitored closely, particularly if experiencing rapid improvements in blood glucose levels, as this can temporarily worsen eye complications
Mojca Jensterle has received lecture honoraria from Novo Nordisk, Eli Lilly, Pfizer, Amgen, Novartis and Sanofi, and is an advisory board member of Novo Nordisk, Eli Lilly, Amgen and Pfizer
US$ 25.30
US$ 24.46
US$ 20.61
